Log in

Sol Gel Technologies News Headlines (NASDAQ:SLGL)

$10.82
+0.01 (+0.09 %)
(As of 02/27/2020 03:47 AM ET)
Today's Range
$10.75
Now: $10.82
$11.32
50-Day Range
$10.60
MA: $12.68
$15.30
52-Week Range
$6.11
Now: $10.82
$21.00
Volume51,827 shs
Average Volume106,990 shs
Market Capitalization$220.62 million
P/E RatioN/A
Dividend YieldN/A
Beta1.27

Headlines

Sol Gel Technologies (NASDAQ SLGL) News Headlines

Source:
DateHeadline
Sol-Gel to Present at the Cowen 40th Annual Health Care ConferenceSol-Gel to Present at the Cowen 40th Annual Health Care Conference
finance.yahoo.com - February 19 at 1:15 PM
Sol Gel Technologies Ltd (NASDAQ:SLGL) Given Consensus Recommendation of "Buy" by BrokeragesSol Gel Technologies Ltd (NASDAQ:SLGL) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - February 19 at 6:44 AM
Zacks: Analysts Expect Sol Gel Technologies Ltd (NASDAQ:SLGL) Will Announce Quarterly Sales of $4.16 MillionZacks: Analysts Expect Sol Gel Technologies Ltd (NASDAQ:SLGL) Will Announce Quarterly Sales of $4.16 Million
www.americanbankingnews.com - February 18 at 4:00 AM
-$0.31 EPS Expected for Sol Gel Technologies Ltd (NASDAQ:SLGL) This Quarter-$0.31 EPS Expected for Sol Gel Technologies Ltd (NASDAQ:SLGL) This Quarter
www.americanbankingnews.com - February 16 at 8:19 AM
The Daily Biotech Pulse: Epizymes Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices OfferingThe Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering
www.benzinga.com - February 14 at 8:51 AM
Sol-Gel down 23% premarket after pricing equity offeringSol-Gel down 23% premarket after pricing equity offering
seekingalpha.com - February 14 at 8:51 AM
Sol-Gel Announces Pricing of Public Offering of Ordinary Shares and Warrants to Purchase Ordinary SharesSol-Gel Announces Pricing of Public Offering of Ordinary Shares and Warrants to Purchase Ordinary Shares
finance.yahoo.com - February 14 at 8:51 AM
Sol-Gel Announces Positive Topline Results from Open-Label, Long-Term Safety Study of Epsolay® for Treatment up to 52 WeeksSol-Gel Announces Positive Topline Results from Open-Label, Long-Term Safety Study of Epsolay® for Treatment up to 52 Weeks
finance.yahoo.com - February 13 at 6:27 PM
Sol Gel Technologies Ltd (NASDAQ:SLGL) Short Interest UpdateSol Gel Technologies Ltd (NASDAQ:SLGL) Short Interest Update
www.americanbankingnews.com - February 12 at 1:40 AM
Sol-Gel Technologies: A Promising Small-Cap Dermatology Player In 2020Sol-Gel Technologies: A Promising Small-Cap Dermatology Player In 2020
seekingalpha.com - February 10 at 7:29 AM
Sol-Gel Provides Product Pipeline Updates and Anticipated Milestones for 2020Sol-Gel Provides Product Pipeline Updates and Anticipated Milestones for 2020
finance.yahoo.com - February 5 at 7:17 AM
Is Sol-Gel Technologies a Buy?Is Sol-Gel Technologies a Buy?
www.fool.com - February 3 at 2:51 PM
Sol-Gel Announces Presentation of Data for its Topical Product Candidates for Acne and Rosacea at the 16th Annual Maui Derm for Dermatologists 2020 MeetingSol-Gel Announces Presentation of Data for its Topical Product Candidates for Acne and Rosacea at the 16th Annual Maui Derm for Dermatologists 2020 Meeting
finance.yahoo.com - January 21 at 5:48 PM
Sol-Gel Hosts Investor Call to Discuss Positive Results from Twyneo® Phase 3 Program in Acne VulgarisSol-Gel Hosts Investor Call to Discuss Positive Results from Twyneo® Phase 3 Program in Acne Vulgaris
finance.yahoo.com - January 8 at 7:16 AM
Sol-Gel Shines In Treating 2 Skin Disorders, NDAs Expected For Both Indications In 2020Sol-Gel Shines In Treating 2 Skin Disorders, NDAs Expected For Both Indications In 2020
seekingalpha.com - January 7 at 9:15 PM
Sol-Gel launches early-stage study of SGT-210 in rare skin disorderSol-Gel launches early-stage study of SGT-210 in rare skin disorder
seekingalpha.com - January 2 at 3:51 PM
Heres Why Sol-Gel Technologies Stock Is Soaring TodayHere's Why Sol-Gel Technologies Stock Is Soaring Today
www.fool.com - December 31 at 4:16 PM
Sol Gels acne cream reduces marks in late-stage studiesSol Gel's acne cream reduces marks in late-stage studies
www.nasdaq.com - December 30 at 4:46 PM
Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne VulgarisSol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne Vulgaris
finance.yahoo.com - December 30 at 4:46 PM
Sol-Gel stock rockets on positive data from acne studySol-Gel stock rockets on positive data from acne study
www.msn.com - December 30 at 4:46 PM
Sol-Gels Twyneo successful in acne studies; shares up 148% premarketSol-Gel's Twyneo successful in acne studies; shares up 148% premarket
seekingalpha.com - December 30 at 4:46 PM
Sol-Gel’s stock jumps 90% on positive acne-drug studiesSol-Gel’s stock jumps 90% on positive acne-drug studies
finance.yahoo.com - December 30 at 4:46 PM
Mid-Afternoon Market Update: Dow Down 150 Points; Savara Shares Spike HigherMid-Afternoon Market Update: Dow Down 150 Points; Savara Shares Spike Higher
www.benzinga.com - December 30 at 2:48 PM
Why Sol-Gel Shares Are Ripping HigherWhy Sol-Gel Shares Are Ripping Higher
www.benzinga.com - December 30 at 11:40 AM
Mid-Morning Market Update: Markets Open Lower; Nio Reports  Strong Q3 ResultsMid-Morning Market Update: Markets Open Lower; Nio Reports Strong Q3 Results
www.benzinga.com - December 30 at 11:40 AM
Sol-Gel Technologies Reports Third Quarter 2019 Financial Results and Corporate UpdateSol-Gel Technologies Reports Third Quarter 2019 Financial Results and Corporate Update
finance.yahoo.com - November 13 at 9:49 AM
Sol-Gel to Present on Potential of Sol-Gel Microencapsulation Technology in Rosacea at 39th Annual Fall Clinical Dermatology ConferenceSol-Gel to Present on Potential of Sol-Gel Microencapsulation Technology in Rosacea at 39th Annual Fall Clinical Dermatology Conference
finance.yahoo.com - October 16 at 8:11 AM
Is Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Trading At A 40% Discount?Is Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Trading At A 40% Discount?
finance.yahoo.com - September 5 at 9:04 AM
Sol-Gel Technologies Reports Second Quarter 2019 Financial Results and Corporate UpdateSol-Gel Technologies Reports Second Quarter 2019 Financial Results and Corporate Update
finance.yahoo.com - August 13 at 12:27 PM
Sol-Gel Announces Pricing of Public Offering of Ordinary SharesSol-Gel Announces Pricing of Public Offering of Ordinary Shares
finance.yahoo.com - August 8 at 8:26 AM
Sol-Gel Technologies Ltd. (SLGL) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseSol-Gel Technologies Ltd. (SLGL) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - August 7 at 1:04 PM
Investors Who Bought Sol-Gel Technologies (NASDAQ:SLGL) Shares A Year Ago Are Now Up 49%Investors Who Bought Sol-Gel Technologies (NASDAQ:SLGL) Shares A Year Ago Are Now Up 49%
finance.yahoo.com - July 11 at 10:44 AM
Sol-Gel up 13% positive Epsolay dataSol-Gel up 13% positive Epsolay data
seekingalpha.com - July 8 at 4:03 PM
Sol-Gel Technologies Shares Positive Results For Skin Breakout CreamSol-Gel Technologies Shares Positive Results For Skin Breakout Cream
finance.yahoo.com - July 8 at 4:03 PM
Sol-Gel Technologies reports positive results in trials of treatment for papulopustular rosaceaSol-Gel Technologies reports positive results in trials of treatment for papulopustular rosacea
www.marketwatch.com - July 8 at 10:59 AM
Sol-Gel Announces Positive Top-Line Results from Epsolay® Phase 3 Program in Papulopustular RosaceaSol-Gel Announces Positive Top-Line Results from Epsolay® Phase 3 Program in Papulopustular Rosacea
finance.yahoo.com - July 8 at 10:59 AM
UPDATE: Sol-Gel Technologies shares soar 9.5% on news of positive results in trials of rosacea treatmentUPDATE: Sol-Gel Technologies shares soar 9.5% on news of positive results in trials of rosacea treatment
finance.yahoo.com - July 8 at 10:59 AM
Sol-Gel inks new deal with Perrigo for antibiotic foams; shares ahead 2%Sol-Gel inks new deal with Perrigo for antibiotic foams; shares ahead 2%
seekingalpha.com - June 28 at 3:56 PM
Sol-Gel Technologies (SLGL) Presents At Raymond James Life Sciences & MedTech Conference - SlideshowSol-Gel Technologies (SLGL) Presents At Raymond James Life Sciences & MedTech Conference - Slideshow
seekingalpha.com - June 20 at 4:12 PM
Sol-Gel Technologies to Host Analyst & Investor Day on July 25, 2019Sol-Gel Technologies to Host Analyst & Investor Day on July 25, 2019
finance.yahoo.com - June 17 at 12:30 PM
Sol-Gel Technologies (SLGL) Presents At 2019 Jefferies Global Healthcare Conference - SlideshowSol-Gel Technologies (SLGL) Presents At 2019 Jefferies Global Healthcare Conference - Slideshow
seekingalpha.com - June 7 at 7:46 PM
Sol-Gel Technologies Announces Seventh Agreement for Generic Product Candidates with PerrigoSol-Gel Technologies Announces Seventh Agreement for Generic Product Candidates with Perrigo
finance.yahoo.com - May 28 at 11:20 AM
Sol-Gel to Present at Upcoming Healthcare Investor Conferences in JuneSol-Gel to Present at Upcoming Healthcare Investor Conferences in June
finance.yahoo.com - May 23 at 4:15 PM
Sol-Gel Technologies Reports First Quarter 2019 Financial Results and Corporate UpdateSol-Gel Technologies Reports First Quarter 2019 Financial Results and Corporate Update
finance.yahoo.com - May 22 at 11:26 AM
Analysts Estimate Sol-Gel Technologies Ltd. (SLGL) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Sol-Gel Technologies Ltd. (SLGL) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - May 14 at 12:01 PM
Sol-Gel Technologies Announces 50% Enrollment in Pivotal Phase III TWIN Program for the Treatment of Acne VulgarisSol-Gel Technologies Announces 50% Enrollment in Pivotal Phase III TWIN Program for the Treatment of Acne Vulgaris
finance.yahoo.com - April 16 at 1:13 PM
Supernus' ADHD Candidate Positive in 4th Phase III StudySupernus' ADHD Candidate Positive in 4th Phase III Study
finance.yahoo.com - April 1 at 6:10 PM
Sol-Gel Technologies Reports Full Year 2018 Financial Results and Provides Corporate UpdateSol-Gel Technologies Reports Full Year 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - March 21 at 4:13 PM
What Percentage Of Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Shares Do Insiders Own?What Percentage Of Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Shares Do Insiders Own?
finance.yahoo.com - February 6 at 4:01 PM
FDA OKs Perrigos generic Zovirax CreamFDA OKs Perrigo's generic Zovirax Cream
seekingalpha.com - February 6 at 11:51 AM
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Featured Article: Monthly Dividend Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel